- Home
- BLKB vs CRNX Comparison
BLKB vs CRNX Comparison
Compare BLKB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLKB
- CRNX
- Stock Information
- Founded
- BLKB 1981
- CRNX 2008
- Country
- BLKB United States
- CRNX United States
- Employees
- BLKB N/A
- CRNX N/A
- Industry
- BLKB Computer Software: Prepackaged Software
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- BLKB Technology
- CRNX Health Care
- Exchange
- BLKB Nasdaq
- CRNX Nasdaq
- Market Cap
- BLKB 3.2B
- CRNX 2.8B
- IPO Year
- BLKB 2004
- CRNX 2018
- Fundamental
- Price
- BLKB $67.95
- CRNX $42.90
- Analyst Decision
- BLKB Hold
- CRNX Buy
- Analyst Count
- BLKB 2
- CRNX 12
- Target Price
- BLKB $70.50
- CRNX $74.45
- AVG Volume (30 Days)
- BLKB 233.7K
- CRNX 1.5M
- Earning Date
- BLKB 10-29-2025
- CRNX 11-06-2025
- Dividend Yield
- BLKB N/A
- CRNX N/A
- EPS Growth
- BLKB N/A
- CRNX N/A
- EPS
- BLKB N/A
- CRNX N/A
- Revenue
- BLKB $1,136,093,000.00
- CRNX $1,392,000.00
- Revenue This Year
- BLKB N/A
- CRNX $420.79
- Revenue Next Year
- BLKB $4.18
- CRNX $993.85
- P/E Ratio
- BLKB N/A
- CRNX N/A
- Revenue Growth
- BLKB N/A
- CRNX 0.51
- 52 Week Low
- BLKB $58.05
- CRNX $24.10
- 52 Week High
- BLKB $88.95
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- BLKB 64.89
- CRNX 55.55
- Support Level
- BLKB $63.84
- CRNX $39.88
- Resistance Level
- BLKB $65.62
- CRNX $44.54
- Average True Range (ATR)
- BLKB 1.69
- CRNX 2.00
- MACD
- BLKB 0.39
- CRNX -0.40
- Stochastic Oscillator
- BLKB 68.17
- CRNX 48.95
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.